Managing Risk in Biomanufacturing
June 28, 2017 - Cytiva
_250.jpg)
We simply cannot avoid all risks and the sta
Hybrid Bioprocessing: A Q&A with Andrew Sinclair
June 28, 2017 - Process Development Forum
Process Development Forum speaks about hybrid bioprocessing with Andrew Sinclair, President and Founder of BioPharm Services
…
N-Glycan Analysis of Biotherapeutic Proteins
June 28, 2017 - BioPharm Intl.
This article summarizes the approaches, challenges, and future perspectives for the characterization of N-glycans in biopharmaceutical products.
…
Immediate, Flexible Capacity with Hydrated Buffers and Process Li
June 28, 2017 - BioPharm Intl.
_250.jpg)
Fluids used in bioprocessing are typically pre
Unifying Continuous Biomanufacturing Operations
June 14, 2017 - BioPharm Intl.
The success of a truly integrated continuous processing platform relies on the collaborative efforts of upstream and downstream specialists.
…
Managing Residual Impurities During Downstream Processing
June 14, 2017 - BioPharm Intl.
Increased understanding of potential impurities has spurred efforts to standardize monitoring procedures.
By Cynthia A. Challener
…
Tips for Protein Purification Method Editing
May 31, 2017 - Cytiva
Protein purification questions and answers from ÄKTA club web chat.
The Extreme Costs of a Bioburden Incident
May 18, 2017 - Cytiva
The cost of bioburden incidents can vastly outweigh the costs of preventing them.
…
Protein Purification Questions and Answers from ÄKTA Club Web Ch
May 18, 2017 - Cytiva
Do you have recurring discussions in your lab that you need input
Fusion Proteins Pose Manufacturability Challenges
May 18, 2017 - BioPharm Intl.
The unique structures of fusion proteins lead to expression, heterogeneity, and stability issues.
By Cynthia A. Challener
…